These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29374371)

  • 1. Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.
    Alp S; Akova M
    Mediterr J Hematol Infect Dis; 2017; 9(1):e2017002. PubMed ID: 28101308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrow-Spectrum Antibacterial Agents.
    Melander RJ; Zurawski DV; Melander C
    Medchemcomm; 2018; 9(1):12-21. PubMed ID: 29527285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
    Stallmach A; Anttila VJ; Hell M; Gwynn S; Merino-Amador P; Petrosillo N; Ráčil Z; Warren T; Wenisch C; Wilcox M
    Z Gastroenterol; 2018 Feb; ():. PubMed ID: 29426057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Woodworth MH; Kraft CS; Meredith EJ; Mehta AK; Wang T; Mamo YT; Dhere T; Sitchenko KL; Patzer RE; Friedman-Moraco RJ
    Transpl Infect Dis; 2018 Apr; 20(2):e12857. PubMed ID: 29446866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant.
    Guzman L; Qiu F; Kalil AC; Mercer DF; Langnas A; Florescu DF
    Transpl Infect Dis; 2018 Apr; 20(2):e12858. PubMed ID: 29427406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
    Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
    Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple nomogram for predicting infectious diseases in adult kidney transplantation recipients.
    Chen RY; Zhang S; Zhuang SY; Li DW; Zhang M; Zhu C; Yu YT; Yuan XD
    Front Public Health; 2022; 10():944137. PubMed ID: 36117592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.
    Wagh H; Arif A; Reddy AJ; Tabaie E; Shekhar A; Min M; Nawathey N; Bachir M; Brahmbhatt H
    Cureus; 2022 Jul; 14(7):e26600. PubMed ID: 35936184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice.
    Meri S; Bunjes D; Cofiell R; Jodele S
    Adv Ther; 2022 Sep; 39(9):3896-3915. PubMed ID: 35781192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key.
    Ferdjallah A; Young JH; MacMillan ML
    Front Pediatr; 2021; 9():634449. PubMed ID: 34386464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.
    Horowitz JG; Gawrys GW; Lee GC; Ramirez BA; Elledge CM; Shaughnessy PJ
    Transpl Infect Dis; 2021 Aug; 23(4):e13689. PubMed ID: 34255395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Lee A; Hong J; Shin DY; Koh Y; Yoon SS; Kim PJ; Kim HG; Kim I; Park HK; Choi Y
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32290456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.
    Whangbo J; Ritz J; Bhatt A
    Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
    Koseck K; Steinberg A; Caliendo G; Meyer J; Kim SS
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28456140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.
    Alonso CD; Marr KA
    Curr Opin Infect Dis; 2013 Aug; 26(4):326-31. PubMed ID: 23806895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?
    Horton LE; Haste NM; Taplitz RA
    Curr Hematol Malig Rep; 2018 Feb; 13(1):59-67. PubMed ID: 29374371
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.